M1RN34:BVMF
Moderna Inc Bdr
R$13,59
0,00%
(0,00) 1D
24 ກ.ລ., 17 ໂມງ 6 ນາທີ 00 ວິນາທີ GMT-3 · BRL
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for M1RN34...
Open
R$14,53
High
R$14,53
Low
R$13,59
Mkt. cap
໒໑,໔໕ ຕື້
Avg. vol.
໖໔,໒໓ ພັນ
Volume
໘,໕໔ ພັນ
52-wk high
R$22,00
52-wk low
R$6,02
Shares outstanding
໓໙໖,໗໙ ລ້ານ
No. of employees
໕ ພັນ
Open
R$14,53
High
R$14,53
Low
R$13,59
Mkt. cap
໒໑,໔໕ ຕື້
Avg. vol.
໖໔,໒໓ ພັນ
Volume
໘,໕໔ ພັນ
52-wk high
R$22,00
52-wk low
R$6,02
Shares outstanding
໓໙໖,໗໙ ລ້ານ
No. of employees
໕ ພັນ
News stories
From sources across the web
The Motley Fool
·
1 ມື້ກ່ອນ
Moderna: A Stock to Watch or a Risky Bet?
Investing.com Nigeria
·
1 ມື້ກ່ອນ
Moderna stock may move 4.2% on July 31 earnings release By Investing.com
Yahoo Finance Singapore
·
2 ມື້ກ່ອນ
Will Moderna (MRNA) Report Negative Earnings Next Week? What You Should Know
Simply Wall Street
·
2 ມື້ກ່ອນ
Moderna (MRNA) Stock Looks Above Fair Value After Cancer Trial News
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine, marketed as Spikevax and a respiratory syncytial virus vaccine, marketed as Mresvia. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines. Wikipedia
About Moderna Inc Bdr
CEOStéphane Bancel
Employees4,7 ພັນ
Foundedກ.ຍ. 2010
Headquarters-
SectorBiotechnology
Websitemodernatx.com
AI content may include mistakes. Learn more